Structural anomalies revealed by neuroimaging studies in the brains of patients with neurofibromatosis type 1 and large deletions

Hofman, 1994, Neurofibromatosis type 1: The cognitive phenotype, J Pediatr, 124, S1, 10.1016/S0022-3476(05)83163-4 North, 1994, Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities, Neurology, 44, 878, 10.1212/WNL.44.5.878 Eldridge, 1989, Neurofibromatosis type 1 (Recklinghausen’s disease). Neurologic and cognitive assessment with sibling controls, Am J Dis Child, 143, 833, 10.1001/archpedi.1989.02150190083027 Legius, 1994, Neurofibromatosis type 1 in childhood: A study of the neuropsychological profile in 45 children, Genet Couns, 5, 51 North, 1997, Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 cognitive disorders task force, Neurology, 48, 1121, 10.1212/WNL.48.4.1121 Huson, 1988, Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales, Brain, 111, 1355, 10.1093/brain/111.6.1355 Carey, 1979, Penetrance and variability in neurofibromatosis: A genetic study of 60 families, Birth Defects: Original Article Series, 15, 271 Rosman, 1967, The brain in multiple neurofibromatosis (von Recklinghausen’s disease): A suggested neuropathological basis for the associated mental defect, Brain, 90, 829, 10.1093/brain/90.4.829 Daston, 1993, Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development, Dev Dyn, 195, 216, 10.1002/aja.1001950307 Daston, 1992, The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes, Neuron, 8, 415, 10.1016/0896-6273(92)90270-N Es, 1996, MRI findings in children with neurofibromatosis type 1: A prospective study, Pediatr Radiol, 26, 478, 10.1007/BF01377205 Itoh, 1994, Neurofibromatosis type 1: The evolution of deep gray and white matter MR abnormalities, Am J Neuroradiol, 15, 1513 Terada, 1996, Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1, Am J Neuroradiol, 17, 755 Duffner, 1989, The significance of MRI abnormalities in children with neurofibromatosis, Neurology, 39, 373, 10.1212/WNL.39.3.373 Bognanno, 1988, Cranial MR imaging in neurofibromatosis, Am J Roentgenol, 151, 381, 10.2214/ajr.151.2.381 Denckla, 1996, Reiss al., Bryan RN, Harris EL, Lee J, Cox CS, Schuerholz LJ. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1, Am J Med Genet, 67, 98, 10.1002/(SICI)1096-8628(19960216)67:1<98::AID-AJMG17>3.0.CO;2-K Ferner, 1993, MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment, J Neurol Neurosurg Psychiatry, 56, 492, 10.1136/jnnp.56.5.492 Kayes, 1992, Sporadic neurofibromatosis 1, mental retardation, and dysmorphism, J Med Genet, 29, 686, 10.1136/jmg.29.10.686 Leppig, 1997, Familial neurofibromatosis 1 microdeletions: Cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata, Am J Med Genet, 73, 197, 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P Leppig, 1996, The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization, Cytogenet Cell Genet, 72, 95, 10.1159/000134171 Wu, 1995, Deletion of the entire NF1 gene detected by FISH: Four deletion patients associated with severe manifestations, Am J Med Genet, 59, 528, 10.1002/ajmg.1320590427 Wu, 1997, Deletion of the entire NF1 gene causing distinct manifestations in a family, Am J Med Genet, 69, 98, 10.1002/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J Upadhyaya, 1998, Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay, Hum Genet, 102, 591, 10.1007/s004390050746 Sevick, 1992, Evolution of white matter lesions in neurofibromatosis type 1: MR findings, Am J Roentgenol, 159, 171, 10.2214/ajr.159.1.1609692 DiPaolo, 1995, Neurofibromatosis type 1: Pathologic substrate of high-signal-intensity foci in the brain, Radiology, 195, 721, 10.1148/radiology.195.3.7754001 Moore, 1996, Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis, Neurology, 46, 1660, 10.1212/WNL.46.6.1660 Horwich, 1983, Aqueductal stenosis leading to hydrocephalus: An unusual manifestation of neurofibromatosis, Am J Med Genet, 14, 577, 10.1002/ajmg.1320140322 Senveli, 1989, Association of von Recklinghausen’s neurofibromatosis and aqueduct stenosis, Neurosurgery, 24, 99, 10.1227/00006123-198901000-00017 Bodensteiner, 1998, Cavum septum pellucidum and cavum vergae in normal and developmentally delayed populations, J Child Neurol, 13, 120, 10.1177/088307389801300305 Bodensteiner, 1990, Wide cavum septum pellucidum: A marker of disturbed brain development, Pediatr Neurol, 6, 391, 10.1016/0887-8994(90)90007-N Miller, 1986, Cavum vergae: Association of neurologic abnormality and diagnosis by MRI, Arch Neurol, 43, 821, 10.1001/archneur.1986.00520080061022 Bodensteiner, 1988, Macro cistema magna: A marker for maldevelopment of the brain?, Pediatr Neurol, 4, 284, 10.1016/0887-8994(88)90067-7 Korf, 1993, Patterns of seizures observed in association with neurofibromatosis 1, Epilepsia, 34, 616, 10.1111/j.1528-1157.1993.tb00437.x